Global Health Crisis: Latest News and Developments

The summary provides key updates on global health issues, including funding appeals for mpox in Africa, drug approvals, and clinical trials scrutiny. Highlights include IOM's appeal for $18.5 million, Lilly's weight-loss drug cutting diabetes risk, J&J's lung cancer treatment approval, and mpox vaccinations in Africa.

A global health crisis unfolds as organizations and companies respond to urgent needs and regulatory changes. The UN's International Organisation for Migration (IOM) has made an appeal for $18.5 million to support healthcare services amid a severe mpox outbreak in East and Southern Africa, highlighting the vulnerability of migrant and displaced populations.

In pharmaceutical news, Eli Lilly's weight-loss drug Zepbound has significantly reduced the risk of type 2 diabetes in overweight pre-diabetic adults, boosting the company's stock by 4.4%. Meanwhile, the FDA has approved Johnson & Johnson's chemotherapy-free lung cancer treatment, potentially rivaling AstraZeneca's leading drug.

On the African continent, communities affected by mpox may soon begin vaccinations, following efforts by the Africa CDC and international pledges. The WHO has declared the outbreak a global public health emergency, further emphasizing the urgency for action.

(With inputs from agencies.)